Synthetic Proteins Engineered for the Modulation of Cell Signaling  by Sidhu, Sachdev
438a Tuesday, February 28, 2012Bcl-2 - the major regulating protein - and its interplay with the mitochondrial
membrane system are being transferred as physiological consequences at the
organelle (mitochondrion) and cellular level is still mysterious. Therefore,
we use a biophysical, solid state NMR based approach to develop a mitochon-
drion based test system, where we can study the physiological response of in-
tact mitochondria of various origin (cancer, healthy, ALS motor neurons) ex
vivo upon apoptotic stress ranging from novel cancer drugs to amyloidogenic
proteins such as A-beta protein or SOD1 protein, the main culprits in AD
and ALS, respectively.
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Reperfusion of a previously ischemic myocardium is a critical life-saving in-
tervention against tissue necrosis, but reperfusion itself also results in signif-
icant damage to myocardium. Many therapeutic strategies such as ischemic
and volatile anesthetic pre- and postconditioning have been suggested but
few have translated effectively to humans. Near infrared and far red light
(NIR) has been demonstrated to protect the myocardium against ischemia
and reperfusion (IR) injury. The beneficial effect of NIR is mediated in
part by an increase in nitric oxide (NO) bioavailability. Under hypoxic con-
ditions, heme-containing proteins such as myoglobin (Mb) and hemoglobin
(Hb) exhibit nitrite reductase activity which results in an increase in NO
bound to Mb and Hb. NIR treatment is thought to cause a photolysis of
MbNO and HbNO which results in an increase in active NO when applied
at the time of reperfusion. We hypothesize that NIR-enhanced NO during
reperfusion modulates mitochondrial bioenergetics by interaction with the
electron transport chain and thereby may induce cardioprotection. Isolated
mitochondria were incubated with substrate and ADP in an air tight chamber.
Oxygen consumption of mitochondria created a hypoxic environment,
simulating conditions of ischemic myocardium. Deoxymyoglobin and nitrite
were added to the reaction chamber during the hypoxic period and then reox-
ygenation was performed in the presence and absence of NIR (670 nm,
50 mW/cm2). A faster reoxygenation of the chamber, corresponding to an
inhibiton of mitochondrial respiration was observed when the reaction was
exposed to NIR during hypoxia and throughout reoxygenation. This mild in-
hibition of mitochondrial respiration by NIR may decrease reactive oxygen
species during reoxygenation and thereby lead to increased cell viability. In-
terestingly, in a diabetic mouse model (db/db) were ischemic or anesthetic
postconditioning fail to protect the myocardium against IR injury, NIR treat-
ment decreased infarct size.
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Mitochondrial potential (DJ) loss is a critical event during myocardial is-
chemia. Potentiometric dye TMRM accumulates inside well-polarized mito-
chondria and is used as an DJ indicator. However, during no-flow ischemia
(NF-ISCH) total TMRM fluorescence may remain unchanged despite DJ
loss. We sought to improve detection of DJ loss during NF-ISCH
using SFT. Langendorff-perfused rabbit hearts (n=8) were stained with
TMRM (400 nM). Motion was abolished by Blebbistatin (5 mM). TMRM
fluorescence was recorded confocally from left ventricular subepicardium
(0.5mm/pixel, 20x objective lens) in control, while perfusing mitochondrial
uncoupler FCCP (5 mM), and after 65515 min of NF-ISCH. In control
SFT revealed distinct peaks (MITO-PEAKs) at spatial frequency of
12.3750.06 mm along the
longitudinal axis of myocytes
(Figure), possibly related to
the sarcomere length. MITO-
PEAKs were greatly de-
pressed after FCCP (not
shown) and NF-ISCH (Fig-
ure). Normalized spectral
power under MITO-PEAKs
was significantly different
between control and FCCP
(p=0.019), and control and
NF-ISCH (p=0.016). In con-trast, total TMRM brightness failed to reveal significant difference (control
vs. FCCP, p = 0.077; control vs. NF-ISCH, p=0.678). Thus, analysis of
MITO-PEAKs in SFT spectrum provides a robust method for detecting
DJ loss in ischemic myocardium.Workshop: Measuring, Modeling, and Designing
Protein Recognition Specificity
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Design of protein interactions is a key challenge in molecular biology and
would open new routes for biomedical research and biotechnology. We devel-
oped a general computational method for designing proteins that bind a surface
patch of interest on a target macromolecule. Favorable interactions between
disembodied amino acid residues and the target surface are identified and
used to anchor de novo designed interfaces. The method was used to design
proteins that bind a conserved surface patch on the stem of the influenza
hemagglutinin (HA) from the 1918 H1N1 pandemic virus. After affinity matu-
ration, two of the designed proteins, HB36 and HB80, bind H1 (Spanish influ-
enza) and H5 (avian influenza) HAs with picomolar affinity. Further, HB80
inhibits the HA fusogenic conformational changes induced at low pH. The
crystal structure of HB36 in complex with 1918/H1 HA revealed that the
actual binding interface is nearly identical to that in the computational design
model. Affinity-increasing mutations isolated through experimental affinity
maturation helped shed light on crucial elements which are missing in compu-
tational design calculations, such as long-range electrostatics. These have been
incorporated in design calculations to improve the computational method’s
ability to generate de novo designed binders and inhibitors. Such designed
binding proteins may be useful as diagnostics, therapeutics, and molecular
probes.
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Over the last decade, therapeutic monoclonal antibodies represent one of the
major breakthroughs for the treatment of cancer and other diseases. To date,
most therapeutic antibodies have been obtained by the humanization of
rodent-derived antibodies, but in recent years, research in antibody engineer-
ing has given rise to a new wave of technologies that promise to transform
the field. Phage-displayed libraries of ‘‘synthetic antibodies’’ use entirely
man-made antigen-binding sites and thus circumvent the need for natural im-
mune repertoires. Using in vitro selections, highly functional antibodies with
fully human frameworks can be generated against virtually any antigen in
a matter of weeks. Access to the encoding DNA allows for rapid affinity mat-
uration, fine tuning of specificity and recasting into different molecular for-
mats. We have developed particularly simple synthetic antibodies that use
a single human framework and limited chemical diversity in restricted regions
of the antigen-binding site. These structural simplifications enhance the perfor-
mance of the libraries, which have yielded highly functional and stable anti-
bodies against numerous diverse antigens. These libraries are capable of
fulfilling all of the roles of natural antibodies, and furthermore, they extend
the use of antibody technologies to many challenging problems, such as the
recognition of conformational changes, post-translational modifications, struc-
tured nucleic acids and integral membrane proteins. Moreover, the recombi-
nant nature of synthetic antibodies makes them ideal reagents that can be
used as crystallization chaperones to aid the elucidation of structures for com-
plex antigens. Extending the synthetic concept even further, we have devel-
oped novel binding scaffolds that enable applications beyond the range of
antibodies, and these include the development of scaffolds that can be synthe-
sized completely using peptide chemistry and scaffolds that fold and function
inside cells.
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The ability to alter or inhibit protein interactions specifically would advance
basic and applied biomolecular science. Increasingly, protein interactions in
the cell are found to be mediated by conserved recognition domains. For this
reason, robust targeting of individual proteins will require solutions to the
